In vivo efficacy of a synthetic coumarin derivative in a murine model of aspergillosis

scientific article

In vivo efficacy of a synthetic coumarin derivative in a murine model of aspergillosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2014PLoSO...9j3039S
P356DOI10.1371/JOURNAL.PONE.0103039
P8608Fatcat IDrelease_vazcep3zuzatxal2oodbu7avvu
P932PMC publication ID4139195
P698PubMed publication ID25140804
P5875ResearchGate publication ID264937936

P50authorBharat SinghQ91998166
Rajesh DaburQ39800503
P2093author name stringSeema Singh
Shilpi Gupta
Madhumanjiri M Gatne
Sunil K Sharma
Sharad Pawar
Gainda L Sharma
P2860cites workTreatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of AmericaQ28263689
Essential gene identification and drug target prioritization in Aspergillus fumigatusQ28469156
Aspergillus fumigatus and aspergillosisQ29617908
What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis.Q33349990
Evaluation of lysine biosynthesis as an antifungal drug target: biochemical characterization of Aspergillus fumigatus homocitrate synthase and virulence studiesQ33983108
Cross-sector review of drivers and available 3Rs approaches for acute systemic toxicity testing.Q34000801
Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.Q34143326
The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapyQ34290097
The virulence of the opportunistic fungal pathogen Aspergillus fumigatus requires cooperation between the endoplasmic reticulum-associated degradation pathway (ERAD) and the unfolded protein response (UPR).Q34775365
Standardization of an experimental murine model of invasive pulmonary aspergillosisQ35091545
Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulationsQ35091593
Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.Q35138591
Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.Q35537748
Functional characterization of the Aspergillus fumigatus CRZ1 homologue, CrzA.Q51963462
Oral acute toxic class method: a successful alternative to the oral LD50 test.Q52938613
Antifungal Activity of Amphotericin B Conjugated to Carbon NanotubesQ57275267
Synthesis and anti-angiogenesis activity of coumarin derivativesQ79772894
Invasive aspergillosis in critically ill patients without malignancyQ80269940
Antifungal activity of some coumarins obtained from species of Pterocaulon (Asteraceae)Q83016437
Proteomic characterization of Aspergillus fumigatus treated with an antifungal coumarin for identification of novel target molecules of key pathwaysQ83990864
Anti-inflammatory and antioxidant activity of coumarins designed as potential fluorescent zinc sensorsQ94538884
Synthetic and natural coumarins as cytotoxic agentsQ36048289
The Aspergillus fumigatus transcriptional regulator AfYap1 represents the major regulator for defense against reactive oxygen intermediates but is dispensable for pathogenicity in an intranasal mouse infection modelQ36313729
What is the current and future status of conventional amphotericin B?Q36481251
In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.Q36558376
Update on echinocandin antifungalsQ37118866
The innate immune response to Aspergillus fumigatusQ37554943
New lead structures in antifungal drug discoveryQ37823634
Immunotherapy of aspergillosisQ37949009
Invasive aspergillosis: resistance to antifungal drugsQ37983464
Invasive aspergillosis: new insights into disease, diagnostic and treatmentQ38070749
Azole resistant Aspergillus fumigatus: an emerging problem.Q38096696
Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A geneQ38283306
A pulmonary aspergillosis case with fatal course in a patient with SIRS clinic.Q39047135
A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study GroupQ40612309
Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosisQ42675899
Efficacy of caspofungin against central nervous system Aspergillus fumigatus infection in mice determined by TaqMan PCR and CFU methodsQ42708837
Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafunginQ44583938
MR features of cerebral aspergillosis in an immunocompetent patient: correlation with histology and elemental analysisQ44772415
Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation.Q46034499
A GHS-consistent approach to health hazard classification of petroleum substances, a class of UVCB substancesQ46187449
Antifungal activity of coumarinsQ46666215
Antitubercular activity of new coumarins.Q50279898
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectaspergillosisQ259626
murine modelQ122890741
P304page(s)e103039
P577publication date2014-01-01
P1433published inPLOS OneQ564954
P1476titleIn vivo efficacy of a synthetic coumarin derivative in a murine model of aspergillosis
P478volume9

Reverse relations

cites work (P2860)
Q52583562Animal Models of Aspergillosis.
Q60920669Antifungal Activity of Coumarin Against Is Related to Apoptosis
Q49900248Antimicrobial Efficacy of Synthetic Pyranochromenones and (Coumarinyloxy)acetamides.
Q48290416Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues.
Q33689767Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.

Search more.